8-KLeadership ChangesRegulation FDExhibits & Filings

HONEYWELL INTERNATIONAL INC 8-K Report, Executive Changes (Apr 1, 2025)

Filed April 1, 2025For Securities:HONHONIV

Summary

Honeywell International Inc. (HON) announced a significant change to its Board of Directors with the appointment of Stephen Williamson, Senior Vice President and Chief Financial Officer of Thermo Fisher Scientific Inc., as an independent director. This appointment is effective April 1, 2025, and Mr. Williamson will also serve on the Audit Committee. His addition brings experienced financial leadership to the board, a move that may be viewed positively by investors seeking strong governance and financial oversight. Mr. Williamson is slated to stand for election at the upcoming 2025 Annual Meeting of Shareowners and will be compensated according to the company's standard non-employee director compensation policies. The company issued a press release on April 1, 2025, to disclose this board appointment, aligning with Regulation FD. This filing does not contain new financial statements or other material operational updates, focusing solely on the governance change. Investors should note that this information is furnished and not deemed filed, impacting its regulatory treatment under the Securities Exchange Act.

Key Highlights

  • 1Appointment of Stephen Williamson, SVP & CFO of Thermo Fisher Scientific, as an independent director to Honeywell's Board.
  • 2Mr. Williamson will also serve as a member of the Audit Committee.
  • 3The appointment is effective April 1, 2025.
  • 4Mr. Williamson will stand for election at the 2025 Annual Meeting of Shareowners.
  • 5Compensation for Mr. Williamson will follow the company's established non-employee director compensation practices.
  • 6The appointment was disclosed via a press release on April 1, 2025.

Frequently Asked Questions

Stephen Williamson is currently the Senior Vice President and Chief Financial Officer of Thermo Fisher Scientific Inc. His appointment to Honeywell's Board of Directors brings considerable financial expertise to the company.

His inclusion on the Audit Committee suggests a continued focus on robust financial oversight and governance. The Audit Committee plays a crucial role in reviewing financial reporting, internal controls, and the audit process, making his expertise particularly valuable.

Mr. Williamson's appointment is effective April 1, 2025. He will stand for formal election by shareowners at the Company’s 2025 Annual Meeting.

This 8-K filing focuses exclusively on the appointment of a new director. There are no new financial statements or other operational or financial disclosures provided in this report. The information is furnished under Regulation FD and not deemed filed for certain purposes.